Please login to the form below
Understanding the authentic patient experience can redefine the success of your clinical trial before you design it
. Su contributes our experience are Origins that there is a willingness within the Pharmaceutical Industry to change attitudes towards clinical trial populations – making them less about academic and clinical outcomes and more inclusive of patient experience and priorities.
This month’s edition of PME features a number of articles and opinion pieces on diversity and inclusion in clinical trials. Our Director, Su Smith was interviewed as part of a featured article by Danny Buckland examining the changing tides in clinical trials. Danny highlights in the piece that though there are 1,518 COVID-19 studies registered on clinicaltrials.gov, less than 0.3% are collecting data on ethnicity. Su contributes our experience are Origins that there is a willingness within the Pharmaceutical Industry to change attitudes towards clinical trial populations – making them less about academic and clinical outcomes and more inclusive of patient experience and priorities. Origins contribute to this changing attitude by helping our pharmaceutical and medical clients to understand the authentic patient experience. This can help to design more patient-centric clinical trials where the trial participants are more representative of the true patient population (and not just the easiest to access), secondary outcomes are inclusive of patient priority and trial materials and communication are written using the lexicon of those that experience the condition and not academics that have defined it.
Read more about how understanding the authentic patient experience can redefine the success of your clinical trial before you design it here: https://origins-insights.com/understanding-the-authentic-patient-experience-can-redefine-the-success-of-your-clinical-trial-before-you-design-it/
Check out this month’s edition of PME for more insights and information: http://www.pmlive.com/pme#/reader/39369/116737
Company Details
Origins - The Patient Focused Specialists
Address:
One Fleet
Ancells Road
Fleet
Hampshire
GU51 2UN
United Kingdom
Latest content on this profile
- Origins' Solutions Offering Explained
- Providing patient solutions that are wanted, needed, accessible, and fit for purpose can help companies to increase the value and success of their products and gain respect and recognition for being truly patient focused.Su Smith explains why this important, and how Origins supports our clients to co-create patient focused materials, at all stages of the product lifecycleFor more about Origins and our different services, visit our website www.origins-patients.com, or contact Su Smith or Mark Corbett to set up a call.
Origins - The Patient Focused Specialists
- Origins' Knowledge Centre
- A collection of resources including webinar recordings, publications and short videos to help you be more patient focussed
Origins - The Patient Focused Specialists
- Origins Insights Offering Explained
- Origins believe that the patient voice not only should but must be included at all stages of the product lifecycle, we believe the question is no longer about why, but how the patient voice is included from drug discovery to commercialisation. In this short video Sheetal Padania describes how Origins’ insights offering helps our clients to understand patient opinion and experience, through a variety of methodologies.For more about Origins and our different services, visit our website: www.origins-patients.com, or contact Sheetal Padania or Mark Corbett to set up a call.
Origins - The Patient Focused Specialists
- Introduction to Origins
- In this short video Mark Corbett, Chief Innovation Officer at Resonant Group, gives a brief introduction to Origins, the patient focused specialist agency.If you'd like to know more, visit the Origins' website www.origins-patients.com or contact Mark directly on LinkedIn.
Origins - The Patient Focused Specialists
- Origins' Strategy Offering Explained
- What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy offering and what it could mean for you.For more about Origins and our different services, visit our website: www.origins-patients.com or contact Su Smith or Mark Corbett to set up a call.
Origins - The Patient Focused Specialists
- End-to-end patient strategy: Making a treatment for patients, with patients
- The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy used more and more often. But what does ‘end-to-end’ encompass, and what does this mean for drug development companies, regulators, healthcare professionals and, of course, patients themselves? Here we explore the concept and why patient voices need to be loud, and heard, during all phases of drug development...
Origins - The Patient Focused Specialists
